Emedastine

Drug Profile

Emedastine

Alternative Names: AL 03432A; CGP 42125; Daren; Emadine; Eurodastin; KB 2413; KG 2413; LY 188695; Remicut

Latest Information Update: 27 Aug 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nippon Organon
  • Developer Alcon; Kolon Pharmaceuticals; Kowa; MSD KK; Saluc Pharma
  • Class Antiallergics; Antihistamines; Benzimidazoles; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Allergic conjunctivitis; Allergic rhinitis; Atopic dermatitis; Dermatitis; Urticaria
  • Discontinued Allergic asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis

Most Recent Events

  • 26 Aug 2010 Alcon has been acquired by Novartis
  • 16 Oct 2006 Discontinued - Clinical-Phase-Unknown for Allergic asthma in Japan (PO)
  • 16 Oct 2006 No development reported - Preregistration for Perennial allergic rhinitis in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top